Keeping Pace in Lung Cancer: Personalizing Treatment in NSCLC: Early-Stage Disease (Stage I-IIIa)

Keeping Pace in Lung Cancer: Personalizing Treatment in NSCLC: Early-Stage Disease (Stage I-IIIa)

Released Monday, 17th April 2023
Good episode? Give it some love!
Keeping Pace in Lung Cancer: Personalizing Treatment in NSCLC: Early-Stage Disease (Stage I-IIIa)

Keeping Pace in Lung Cancer: Personalizing Treatment in NSCLC: Early-Stage Disease (Stage I-IIIa)

Keeping Pace in Lung Cancer: Personalizing Treatment in NSCLC: Early-Stage Disease (Stage I-IIIa)

Keeping Pace in Lung Cancer: Personalizing Treatment in NSCLC: Early-Stage Disease (Stage I-IIIa)

Monday, 17th April 2023
Good episode? Give it some love!
Rate Episode
List

Host: Mark Socinski, MD

Guest: Patrick Forde, M.B.B.Ch.

The optimal management of non-small cell lung cancer (NSCLC) has fundamentally changed. Targeted agents, mono and combination immunotherapy, and immunochemotherapy options continue to emerge. You also need to factor in new and investigational neoadjuvant and adjuvant regimens. So how do you determine which patients will benefit most within this new landscape of options? Join Drs. Mark Socinski and Patrick Forde as they address these questions and provide a measure of order in the chaos.

Show More